Stroke and Stem Cell-based Therapy

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378041%3A_____%2F16%3A00475925" target="_blank" >RIV/68378041:_____/16:00475925 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Stroke and Stem Cell-based Therapy
Original language description
Ischaemic heart disease, stroke, lower respiratory infections and chronic obstructive lung disease remained the top causes of mobidity and mortality during the past decade (1). Despite the improvement in the acute treatment options, the stroke mortality is estimated more than 20% and the numbers of disabled people reach almost 30%. The incidence of cerebrovascular accidents range between 185-300/100 000 in high-income countries. The prevalence is increasing with age (2), rates increased from approximately 5 000/100 000 in subjects aged less than 75 years to 10 000 or more per 100 000 in those aged 80+(3).The cost of treatment and social services after stroke in the United States exceeds $ 43 billion annually (4), the cost of stroke in EU are estimated of €5000 – 30 000 per patient during the first year after the accident (3).More than 80% of accidents of cerebrovascular disease events are ischemic stroke, the haemorrhagic attacks occur only in 20%.
Czech name
—
Czech description
—

Project
<a href="/en/project/LO1309" target="_blank" >LO1309: Cell Therapy and Tissue Repair</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)